Table of Content




1. Executive Summary


2. Global Cell and Gene Therapy Manufacturing Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cell and Gene Therapy Manufacturing Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Cell and Gene Therapy Manufacturing Market by Indication
3.3.1: Oncology Diseases
3.3.2: Cardiovascular Diseases
3.3.3: Orthopedic Diseases
3.3.4: Ophthalmology Diseases
3.3.5: Central Nervous System Disorders
3.3.6: Infectious Diseases
3.3.7: Others


3.4: Global Cell and Gene Therapy Manufacturing Market by Type
3.4.1: Cell Therapy
3.4.2: Gene Therapy

3.5: Global Cell and Gene Therapy Manufacturing Market by Application
3.5.1: Clinical Manufacturing
3.5.2: Commercial Manufacturing

3.6: Global Cell and Gene Therapy Manufacturing Market by End Use
3.6.1: Pharmaceutical & Biotechnology Companies
3.6.2: Academic & Research Institutes
3.6.3: Others



4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Cell and Gene Therapy Manufacturing Market by Region
4.2: North American Cell and Gene Therapy Manufacturing Market
4.2.1: North American Cell and Gene Therapy Manufacturing Market by Type: Cell Therapy and Gene Therapy
4.2.2: North American Cell and Gene Therapy Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others

4.3: European Cell and Gene Therapy Manufacturing Market
4.3.1: European Cell and Gene Therapy Manufacturing Market by Type: Cell Therapy and Gene Therapy
4.3.2: European Cell and Gene Therapy Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others

4.4: APAC Cell and Gene Therapy Manufacturing Market
4.4.1: APAC Cell and Gene Therapy Manufacturing Market by Type: Cell Therapy and Gene Therapy
4.4.2: APAC Cell and Gene Therapy Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others

4.5: ROW Cell and Gene Therapy Manufacturing Market
4.5.1: ROW Cell and Gene Therapy Manufacturing Market by Type: Cell Therapy and Gene Therapy
4.5.2: ROW Cell and Gene Therapy Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cell and Gene Therapy Manufacturing Market by Indication
6.1.2: Growth Opportunities for the Global Cell and Gene Therapy Manufacturing Market by Type
6.1.3: Growth Opportunities for the Global Cell and Gene Therapy Manufacturing Market by Application
6.1.4: Growth Opportunities for the Global Cell and Gene Therapy Manufacturing Market by End Use
6.1.5: Growth Opportunities for the Global Cell and Gene Therapy Manufacturing Market by Region

6.2: Emerging Trends in the Global Cell and Gene Therapy Manufacturing Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cell and Gene Therapy Manufacturing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell and Gene Therapy Manufacturing Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Lonza
7.2: Catalent
7.3: Thermo Fisher Scientific
7.4: Charles River Laboratories
7.5: WuXi AppTec
7.6: Merck
7.7: Takara Bio
7.8: Oxford Biomedica
7.9: Cell and Gene Therapy Catapult
7.10: Genezen